Nutex Health, Inc.'s latest moves, explained simply — so you know why the numbers change.
Straight from SEC filings · updated 6 Aug 2026Nutex shifted to pay-on-collected fees and expects lower arbitration costs due to CMS fee reductions from $115 to $15.
Shareholders learn how the company performed in the first three months of 2026 to evaluate investment progress.
Detailed financial data shows revenue, expenses, and assets to help investors track company health quarterly.
Shareholders voted to keep leadership in place and approved compensation, showing confidence in company direction.
Annual earnings show total company performance and help investors decide if the business is growing or shrinking.
Complete yearly financial data reveals total revenue, profits, debt, and assets to assess long-term company strength.
Stocky reads Nutex Health, Inc.'s official filings with the U.S. Securities and Exchange Commission (SEC) — the 8-K, 10-Q and 10-K reports every public company must file — and summarizes each one in plain English, with a link back to the original document.
Nutex Health, Inc.'s most recent tracked filing was a 8-K on 21 Jul 2026: Amended HaloMD dispute resolution deal through December 2029.
No. These event summaries are educational — generated from public SEC filings to help beginners understand what a company is doing. They are not buy or sell recommendations.
Educational, not financial advice. Company events summarized from public SEC filings.
Data as of 6 Aug 2026.